Brief: Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing
06/11/2017 22:10
Nov 6 (Reuters) - Nymox Pharmaceutical Corp NYMX.O
* Nymox Pharmaceutical Corp qtrly loss per share $0.09 - SEC
filing
Source text: (http://bit.ly/2j7iBgX)
Further company coverage: NYMX.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba